Sinonasal teratocarcinosarcoma.
Sinonasal teratocarcinosarcoma (SNTCS) is a distinctly rare tumor characterized by a variegated histologic architecture of epithelial and mesenchymal components. By reported accounts, SNTCS is a highly malignant tumor displaying rapid, aggressive growth. Prognosis is poor: less than 45% of all patients survive past 5 years. Combination surgery and radiotherapy currently appear to be the most effective treatment. This report presents a 76-year-old African American man with a SNTCS in the right nasal cavity and paranasal sinuses. The patient was treated with combination surgical excision and postoperative radiation therapy. The clinical and pathologic features and clinical course will be discussed.
Chao
K Kenneth
KK
Department of Radiation Oncology, University of Texas Health Science Center at San Antonio and Cancer Therapy and Research Center, San Antonio, Texas 78229, USA.
Eng
Tony Y
TY
Barnes
Jonathan
J
Dahiya
Rajiv
R
D000368:Aged; D002296:Carcinosarcoma / Q000175:diagnosis* / Q000532:radiotherapy / Q000601:surgery; D006801:Humans; D008297:Male; D010255:Paranasal Sinus Neoplasms / Q000175:diagnosis* / Q000532:radiotherapy / Q000601:surgery; D018243:Teratocarcinoma / Q000175:diagnosis* / Q000532:radiotherapy / Q000601:surgery